Elective conversion to sirolimus vs. continued tacrolimus in kidney transplantation (the 3c study): Results of a randomized trial

Ítems similars

• Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
  per: Haynes, R, et al.
  Publicat: (2014)
• Results of a Large Randomized Controlled Trial of Alemtuzumab-Versus Basiliximab-Based Induction Therapy in Kidney Transplantation
  per: Haynes, R, et al.
  Publicat: (2014)
• Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype.
  per: Carroll, R, et al.
  Publicat: (2013)
• Sirolimus in combination with low-dose extended-release tacrolimus in kidney transplant recipients
  per: Zhi-yu Zou, et al.
  Publicat: (2023-12-01)
• Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
  per: Haynes, R, et al.
  Publicat: (2014)